Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stryker Buys Concentric Medical To Enter Acute Ischemic Stroke Market

This article was originally published in The Gray Sheet

Executive Summary

Stryker will gain access to the acute ischemic stroke market by acquiring privately held Concentric Medical for $135 million under a definitive agreement announced Aug. 31.
Advertisement

Related Content

Stryker Devices Get First-Line US FDA Go-Ahead For Stroke
Endovascular Thrombectomy Shows No Benefit Over Standard Of Care In MR RESCUE
Endovascular Thrombectomy Shows No Benefit Over Standard Of Care In MR RESCUE
New Products In Brief
Stryker M&A Strategy Intact Under New CEO With Latest Deal For Stroke Care
Stryker Debuts Next-Gen Clot Remover For Ischemic Stroke, Boosting Neuro Competition
Covidien Aims To Double Sales In Emerging Markets By 2017
News In Brief
Stryker Buys Target Neurovascular Biz From Boston Scientific For $1.5 Billion
Stryker Buys Target Neurovascular Biz From Boston Scientific For $1.5 Billion

Topics

Advertisement
UsernamePublicRestriction

Register

MT030510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel